Results 181 to 190 of about 17,056 (203)

High anti-CCP antibody titres predict good response to rituximab in patients with active rheumatoid arthritis

Joint Bone Spine, 2014
Sébastien Ottaviani, Carine Roy, Elisabeth Palazzo   +2 more
exaly  

Anti-streptavidin IgG antibody interference in anti-cyclic citrullinated peptide (CCP) IgG antibody assays is a rare but important cause of false-positive anti-CCP results

Clinical Chemistry and Laboratory Medicine, 2018
Mario BERTH
exaly  

Usefulness of anti-CCP antibodies in patients with hepatitis C virus infection with or without arthritis, rheumatoid factor, or cryoglobulinemia

Clinical Rheumatology, 2007
Hsiang-Cheng Chen, Chen-Hung Chen, Jenn-Haung Lai   +2 more
exaly  

Anti-CCP antibodies have more diagnostic impact than rheumatoid factor (RF) in a population tested for RF

Clinical Rheumatology, 2007
Ana Ligia Bender
exaly  

Performance characteristic of anti-cyclic citrullinated peptide (CCP) assay on Korean rheumatoid arthritis (RA) patients and healthy controls

Journal of Pharmaceutical and Biomedical Analysis, 2014
Jae-Chul Pyun, Min-Jung Kang, Hyun Ok Kim   +2 more
exaly  

Anti-cyclic citrullinated peptide (CCP) antibodies in patients with long-standing rheumatoid arthritis and their relationship with extra-articular manifestations

Clinical Biochemistry, 2006
Tercan US, Cengiz Korkmaz, Yurdanur Akgün   +2 more
exaly  

Comparative study of anti-CCP and RF for the diagnosis of rheumatoid arthritis

APLAR Journal of Rheumatology, 2007
Fereydoun Davatchi
exaly  

Organizing Pneumonia with a Positive Result for Anti-CCP Antibodies as the First Clinical Presentation of Rheumatoid Arthritis

Internal Medicine, 2010
Kosaku Komiya, Akira Hebisawa, Shinji Teramoto   +2 more
exaly  

Behçet hastalarında anti ccp düzeyleri

2011
UZKESER, Hülya, KARATAY, SALİHA, ENGİN, RAGİP İSMAİL, ÇAKICI, ÖZGÜR, YILDIRIM, Kadir, KARAKUZU, ALİ   +5 more
openaire   +1 more source

Anti-CCP antibodies, a highly specific marker for (early) rheumatoid arthritis

Clinical and Applied Immunology Reviews, 2004
Erik R Vossenaar, Walther J van Venrooij
exaly